Differential multiple sclerosis treatment allocation between Australia & New Zealand impacts on clinical course but not quality of life

AZZ Phyo; A De Livera; G Jelinek; C Brown; E O'Kearney; S Neate; K Taylor; W Bevens; S Simpson; T Weiland

Conference Proceedings

Differential multiple sclerosis treatment allocation between Australia & New Zealand impacts on clinical course but not quality of life

AZZ Phyo, A De Livera, G Jelinek, C Brown, E O'Kearney, S Neate, K Taylor, W Bevens, S Simpson, T Weiland

MULTIPLE SCLEROSIS JOURNAL | SAGE PUBLICATIONS LTD | Published : 2018

University of Melbourne Researchers

George Jelinek Author

Cynthia Brown Author

Sandra Neate Author

Keryn Taylor Author

Related Projects (1)

IDENTIFYING AND MODIFYING LIFESTYLE RISK FACTORS TO IMPROVE HEALTH OUTCOMES IN MULTIPLE SCLEROSIS

Multiple Sclerosis (MS) is a neurological disorder affecting ~25000 Australians. Promising evidence is emerging that modifying lifestyle fac..

Grants

Awarded by National Health and Medical Research Council

Awarded by National Health and Medical Research Council of Australia

Funding Acknowledgements

The study was funded by the Bloom Foundation, Wal Pisciotta, and the Horne Family Charitable Trust. CM is funded by an Early Career Fellowship from the National Health and Medical Research Council (ID 1120014).

Keywords

Neurosciences

Science & Technology

Clinical Neurology

Life Sciences & Biomedicine

Neurosciences & Neurology